1. Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells

   • Yoshinori Nio
   • Jacob Zighelboim
   • Benjamin Bonavida

   OriginalPaper Pages: 1 - 8

2. Comparative metabolism and pharmacokinetics of doxorubicin and 4′-epidoxorubicin in plasma, heart and tumor of tumor-bearing mice

   • Wim J. F. van der Vijgh
   • Paul A. Maessen
   • Herbert M. Pinedo

   OriginalPaper Pages: 9 - 12

3. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles

   • Claudette Verdun
   • Francis Brasseur
   • Michel Roland

   OriginalPaper Pages: 13 - 18

4. Testicular endocrine effects of alkane methanesulphonates related to the Leydig cell cytotoxic compound, EDS

   • G. Edwards
   • H. Jackson
   • I. D. Morris

   OriginalPaper Pages: 19 - 25

5. Triple combination of retinoic acid plus actinomycin D plus dimethylformamide induces differentiation of human acute myeloid leukaemic blasts in primary culture

   • Hassan Tawhid Hassan
   • John Rees

   OriginalPaper Pages: 26 - 30

6. Efficacy of ganglioside treatment in reducing functional alterations induced by vincristine in rabbit peripheral nerves

   • Franco Di Gregorio
   • Giorgio Favaro
   • Mario G. Fiori

   OriginalPaper Pages: 31 - 36

7. Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo

   • Guan Chen
   • W. Jens Zeller

   OriginalPaper Pages: 37 - 41

8. Genotoxicity and cell cycle effects of platinum-based imaging agents in cisplatin-resistant human tumour cells

   • J. Lean
   • P. G. Parsons
   • C. Ward

   OriginalPaper Pages: 42 - 46

9. The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung

   • The Kyushu Lung Cancer Chemotherapy Study Group
   • Nobuyuki Hara
   • Masatetsu Hokama

   OriginalPaper Pages: 47 - 51

10. A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group

    • Lucio Crino
    • Maurizio Tonato
    • Stephen Davis

    OriginalPaper Pages: 52 - 56

11. Biological Modification of protracted infusion of 5-fluorouracil with weekly leucovorin

    • Cynthia Gail Leichman
    • Lawrence Leichman
    • William Waugh

    OriginalPaper Pages: 57 - 61

12. Carboplatin in the treatment of metastatic carcinoid tumours and paraganglioma: a phase II study

    • D. I. Jodrell
    • I. E. Smith

    OriginalPaper Pages: 62 - 64

13. Assessment of renal toxicity by urinary enzymes in patients receiving chemotherapy with 8-methyl-8-acetylenic-putrescine

    • James Carmichael
    • Brian M. J. Cantwell
    • Andrew W. Skillen

    OriginalPaper Pages: 65 - 66

14. Flavone acetic acid distribution in human malignant tumors

    • Giovanna Damia
    • Andrea Freschi
    • Maurizio D’Incalci

    OriginalPaper Pages: 67 - 70

15. Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide

    • H. Anderson
    • M. J. Lind
    • K. B. Carroll

    OriginalPaper Pages: 71 - 74

16. Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione

    • Robert C. Stein
    • Mitchell Dowsett
    • R. Charles Coombes

    OriginalPaper Pages: 75 - 78

17. Differential cytotoxicity of Combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines

    • Alan T. McGown
    • Brian W. Fox

    Short Communication Pages: 79 - 81

18. Acknowledgement to reviewers

    Acknowledgments Pages: 82 - 82